Drug Manufacturer Pricing Disclosures: 2018 Update
Proposed drug pricing transparency and disclosure legislation has been introduced and is pending in numerous states. During the first half of 2018 only two states (Oregon and Connecticut) passed new laws imposing price disclosure requirements on drug manufacturers. Maine expanded its existing disclosure law. Also of note was the U.S. Court of Appeals for the Fourth Circuit finding Maryland’s Anti-Gouging law unconstitutional.
To read the full article, please click here.
“Drug Manufacturer Pricing Disclosures: 2018 Update,” by Merle M. DeLancey, Jr., was published in the October 2018 edition of Pratt’s Government Contracting Law Report (Vol. 4, No. 10), an A.S. Pratt Publication, LexisNexis. Reprinted with permission.
This article was first published in Blank Rome’s Government Contracts Navigator blog in July 2018, and was updated for publication in Pratt’s Government Contracting Law Report.